{"id":192638,"name":"THE BIOSIMILARS FORUM","slug":"the-biosimilars-forum","state":"DC","country":"United States of America","description":"Non-profit Organization","totalSpending":2640000,"filings":30,"yearlySpending":[{"year":2019,"income":360000},{"year":2020,"income":360000},{"year":2021,"income":360000},{"year":2022,"income":360000},{"year":2023,"income":400000},{"year":2024,"income":400000},{"year":2025,"income":400000}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"ACC","display":"Accounting"},{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["THORN RUN PARTNERS"],"lobbyists":["ALEX DELPIZZO","STUART CHAPMAN","JESSIE BRAIRTON","THAYER ROBERTS"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Medicare reimbursement issues; FDA regulations of biosimilars.","Medicare reimbursement issues; FDA regulations of biosimilars.","Medicare reimbursement issues; FDA regulations of biosimilars.","Medicare reimbursement issues; FDA regulations of biosimilars.","Medicare reimbursement issues; FDA regulations of biosimilars."]}